Chemoresistance in Gliomas

Overview

Journal Mol Cell Biochem

Publisher Springer

Specialty Biochemistry

Date 2008 Feb 9

PMID 18259841

Citations 63

Authors

Chen Lu

Amal Shervington

Affiliations

Soon will be listed here.

Abstract

Despite improved knowledge and advanced treatments of gliomas, the overall survival rate for glioma patients remains low. Gliomas comprise of significant cell heterogeneity that contains a large number of multidrug resistant (MDR) phenotypes and cancer stem cells (CSCs), a combination that may contribute to the resistance to treatment. This article reviews the MDR related genes, major-vault protein (MVP), anti-apoptotic protein (Bcl-2) and the molecular mechanisms that may contribute to chemoresistance, in addition to the upregulated MDR phenotypes present in CSCs that has recently been identified in gliomas. Moreover, future potential therapies that modulate MDR phenotypes and CSCs are also reviewed. An improved understanding of MDR may lead to a combined treatment, targeting both CSCs and their protective MDR phenotypes leading eventually to attractive strategies for the treatment of gliomas.

Citing Articles

ABCG2 Expression as a Potential Survival Predictor in Human Gliomas.

Raguz M, Tarle M, Muller D, Tomasovic-Loncaric C, Chudy H, Marinovic T Int J Mol Sci. 2024; 25(6).

PMID: 38542090 PMC: 10969902. DOI: 10.3390/ijms25063116.

Dysregulation of calcium homeostasis in cancer and its role in chemoresistance.

Kumari N, Pullaguri N, Rath S, Bajaj A, Sahu V, Ealla K Cancer Drug Resist. 2024; 7:11.

PMID: 38510751 PMC: 10951838. DOI: 10.20517/cdr.2023.145.

TIM-3 as a promising target for cancer immunotherapy in a wide range of tumors.

Sauer N, Janicka N, Szlasa W, Skinderowicz B, Kolodzinska K, Dwernicka W Cancer Immunol Immunother. 2023; 72(11):3405-3425.

PMID: 37567938 PMC: 10576709. DOI: 10.1007/s00262-023-03516-1.

Colorectal cancer and therapy response: a focus on the main mechanisms involved.

Tirendi S, Marengo B, Domenicotti C, Bassi A, Almonti V, Vernazza S Front Oncol. 2023; 13:1208140.

PMID: 37538108 PMC: 10396348. DOI: 10.3389/fonc.2023.1208140.

In Vitro and In Vivo Drug-Response Profiling Using Patient-Derived High-Grade Glioma.

Rajan R, Fernandez-Vega V, Sperry J, Nakashima J, Do L, Andrews W Cancers (Basel). 2023; 15(13).

PMID: 37444398 PMC: 10339991. DOI: 10.3390/cancers15133289.

References

Calatozzolo C, Gelati M, Ciusani E, Sciacca F, Pollo B, Cajola L . Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma. J Neurooncol. 2005; 74(2):113-21. DOI: 10.1007/s11060-004-6152-7. View

Kong L, Siva A, Rome L, Stewart P . Structure of the vault, a ubiquitous celular component. Structure. 1999; 7(4):371-9. DOI: 10.1016/s0969-2126(99)80050-1. View

Filipits M, Pohl G, Stranzl T, Suchomel R, Scheper R, Jager U . Expression of the lung resistance protein predicts poor outcome in de novo acute myeloid leukemia. Blood. 1998; 91(5):1508-13. View

Bahr O, Rieger J, Duffner F, Meyermann R, Weller M, Wick W . P-glycoprotein and multidrug resistance-associated protein mediate specific patterns of multidrug resistance in malignant glioma cell lines, but not in primary glioma cells. Brain Pathol. 2003; 13(4):482-94. PMC: 8095903. DOI: 10.1111/j.1750-3639.2003.tb00479.x. View

Streffer J, Rimner A, Rieger J, Naumann U, Rodemann H, Weller M . BCL-2 family proteins modulate radiosensitivity in human malignant glioma cells. J Neurooncol. 2002; 56(1):43-9. DOI: 10.1023/a:1014448721327. View

Matsumoto Y, Miyake K, Kunishio K, Tamiya T, Seigo N . Reduction of expression of the multidrug resistance protein (MRP)1 in glioma cells by antisense phosphorothioate oligonucleotides. J Med Invest. 2004; 51(3-4):194-201. DOI: 10.2152/jmi.51.194. View

Brown A, Yang W, Schmidt N, Carroll R, Leishear K, Rainov N . Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin. Hum Gene Ther. 2003; 14(18):1777-85. DOI: 10.1089/104303403322611782. View

Koda M, Reszec J, Sulkowska M, Kanczuga-Koda L, Sulkowski S . Expression of the insulin-like growth factor-I receptor and proapoptotic Bax and Bak proteins in human colorectal cancer. Ann N Y Acad Sci. 2005; 1030:377-83. DOI: 10.1196/annals.1329.047. View

Baguley B . Tumor stem cell niches: a new functional framework for the action of anticancer drugs. Recent Pat Anticancer Drug Discov. 2008; 1(1):121-7. DOI: 10.2174/157489206775246494. View

10.

Dean M, Rzhetsky A, Allikmets R . The human ATP-binding cassette (ABC) transporter superfamily. Genome Res. 2001; 11(7):1156-66. DOI: 10.1101/gr.184901. View

11.

Benyahia B, Huguet S, Decleves X, Mokhtari K, Criniere E, Bernaudin J . Multidrug resistance-associated protein MRP1 expression in human gliomas: chemosensitization to vincristine and etoposide by indomethacin in human glioma cell lines overexpressing MRP1. J Neurooncol. 2004; 66(1-2):65-70. DOI: 10.1023/b:neon.0000013484.73208.a4. View

12.

Kitazono M, Okumura H, Ikeda R, Sumizawa T, Furukawa T, Nagayama S . Reversal of LRP-associated drug resistance in colon carcinoma SW-620 cells. Int J Cancer. 2001; 91(1):126-31. DOI: 10.1002/1097-0215(20010101)91:1<126::aid-ijc1018>3.0.co;2-8. View

13.

Jedlitschky G, Leier I, Buchholz U, Center M, Keppler D . ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. Cancer Res. 1994; 54(18):4833-6. View

14.

Slesina M, Inman E, Rome L, Volknandt W . Nuclear localization of the major vault protein in U373 cells. Cell Tissue Res. 2005; 321(1):97-104. DOI: 10.1007/s00441-005-1086-8. View

15.

Tyagi D, Sharma B, Gupta S, Kaul D, Vasishta R, Khosla V . Expression of Bcl2 proto-oncogene in primary tumors of the central nervous system. Neurol India. 2002; 50(3):290-4. View

16.

Cole S, Bhardwaj G, Gerlach J, MACKIE J, Grant C, Almquist K . Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science. 1992; 258(5088):1650-4. DOI: 10.1126/science.1360704. View

17.

Fels C, Schafer C, Huppe B, Bahn H, Heidecke V, Kramm C . Bcl-2 expression in higher-grade human glioma: a clinical and experimental study. J Neurooncol. 2000; 48(3):207-16. DOI: 10.1023/a:1006484801654. View

18.

Zhou S, Schuetz J, Bunting K, Colapietro A, Sampath J, Morris J . The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med. 2001; 7(9):1028-34. DOI: 10.1038/nm0901-1028. View

19.

Cole S, Sparks K, Fraser K, Loe D, Grant C, WILSON G . Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res. 1994; 54(22):5902-10. View

20.

Scheffer G, Wijngaard P, Flens M, Izquierdo M, Slovak M, Pinedo H . The drug resistance-related protein LRP is the human major vault protein. Nat Med. 1995; 1(6):578-82. DOI: 10.1038/nm0695-578. View